RI-MUHC team uncovers new mechanism of inflammation in muscular dystrophy
A new study reveals how signals sent from damaged muscles to the bone marrow can induce long-lasting...
Fall 2021 CIHR competition results
RI-MUHC teams received $9.5 million in project funding
Three renewed Canada Research Chairs for RI-MUHC researchers
Ahmad Haidar, Dennis Jensen and Ian Watson are part of the McGill University cohort of 17 new and renewed Canada Research Chairs
Marcel Behr appointed interim director McGill Interdisciplinary Initiative in Infection and Immunity
Founding director Don Sheppard to direct Antimicrobial Resistance Task Force at the Public Health Agency...
Unraveling the complexity of vitamin B12 diseases
Nature Communications study has implications for treatment of patients and genetic counselling
RI-MUHC researchers led one of Québec Science magazine’s top 10 discoveries of the year
Jean-Jacques Lebrun and his team have discovered a promising treatment for triple negative breast cancer
Three RI-MUHC research projects funded in special CIHR calls
Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence
$2M to the MUHC Foundation for precision cancer care
BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program
McGill team’s index predicts coma recovery with 100% accuracy
New Adaptive Reconfiguration Index has crucial implications for clinical management and decision-making in unconscious and unresponsive...
FANCI: a new gene at the origin of some cases of ovarian cancer
For the first time, researchers link mutations in the FANCI gene to the risk of developing ovarian cancer